Flavonoids, proanthocyanidins, and cancer risk: A network of case-control studies from Italy

Nutrition and Cancer

Volumn 62, Issue 7, 2010, Pages 871-877

  Rossi, Marta ^a,b   Bosetti, Cristina ^a   Negri, Eva ^a   Lagiou, Pagona ^c   La Vecchia, Carlo ^a,b  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

FLAVANONE; FLAVONE; FLAVONOID; FLAVONOL; ISOFLAVONE; PROANTHOCYANIDIN;

ARTICLE; BREAST CANCER; CANCER RISK; CASE CONTROL STUDY; COLORECTAL CANCER; CONTROLLED STUDY; DIETARY INTAKE; ESOPHAGUS CANCER; HUMAN; ITALY; KIDNEY CANCER; LARYNX CANCER; MAJOR CLINICAL STUDY; MOUTH CANCER; OVARY CANCER; PROSTATE CANCER; RISK REDUCTION;

BREAST NEOPLASMS; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; ESOPHAGEAL NEOPLASMS; FLAVONOIDS; HUMANS; ITALY; KIDNEY NEOPLASMS; LOGISTIC MODELS; NEOPLASMS; ODDS RATIO; PROANTHOCYANIDINS;

EID: 77958011208     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1080/01635581.2010.509534     Document Type: Article

References (70)

1. World Cancer Research Fund and American Institute for Cancer Research: Food, Nutrition and the Prevention of Cancer: A Global Perspective. Washington, DC: American Institute for Cancer Research, 1997.
2. World Cancer Research Fund and American Institute for Cancer Research: Food, Nutrition, Physical Activity and the Prevention of Cancer: A Global Perspective. Washington, DC: American Institute for Cancer Research, 2007.
3. La Vecchia C and Tavani A: Fruit and vegetables, and human cancer. Eur J Cancer Prev 7, 3-8, 1998.
4. La Vecchia C and Bosetti C: Diet and cancer risk in Mediterranean countries: open issues. Public Health Nutr 9, 1077-1082, 2006.
5. Manach C, Scalbert A, Morand C, Remesy C, and Jimenez L: Polyphenols: food sources and bioavailability. Am J Clin Nutr 79, 727-747, 2004.
6. Ross JA and Kasum CM: Dietary flavonoids: bioavailability, metabolic effects, and safety. Annu Rev Nutr 22, 19-34, 2002.
7. Nijveldt RJ, van Nood E, van Hoorn DE, Boelens PG, van Norren K, et al.: Flavonoids: a review of probable mechanisms of action and potential applications. Am J Clin Nutr 74, 418-425, 2001.
8. Peterson J and Dwyer J: Flavonoids: dietary occurrence and biochemical activity. Nutr Res 18, 1995-2018, 1998.
9. Stoner GD and Mukhtar H: Polyphenols as cancer chemopreventive agents. J Cell Biochem Suppl 22, 169-180, 1995.
10. La Vecchia C, Decarli A, and Pagano R: Vegetable consumption and risk of chronic disease. Epidemiology 9, 208-210, 1998.
11. Trichopoulou A, Naska A, Antoniou A, Friel S, Trygg K, et al.: Vegetable and fruit: the evidence in their favour and the public health perspective. Int J Vitam Nutr Res 73, 63-69, 2003.
12. Arts IC and Hollman PC: Polyphenols and disease risk in epidemiologic studies. Am J Clin Nutr 81, 317S-325S, 2005.
13. Neuhouser ML: Dietary flavonoids and cancer risk: evidence from human population studies. Nutr Cancer 50, 1-7, 2004.
14. U. S. Department of Agriculture: Iowa State University Database on the Isoflavone Content of Foods, Release 1.3, 2002. Beltsville, MD: USDA, 2002.
15. U. S. Department of Agriculture: USDA Database for the Flavonoid Content of Selected Foods. Beltsville, MD: USDA, 2003.
16. U. S. Department of Agriculture: USDA Database for the Proanthocyanidin Content of Selected Foods. Beltsville, MD: USDA, 2004.
17. De Stefani E, Ronco A, Mendilaharsu M, and Deneo-Pellegrini H: Diet and risk of cancer of the upper aerodigestive tract-II. Nutrients. Oral Oncol 35, 22-26, 1999. (Pubitemid 28546840)
18. Lagiou P, Samoli E, Lagiou A, Peterson J, Tzonou A, et al.: Flavonoids, vitamin C and adenocarcinoma of the stomach. Cancer Causes Control 15, 67-72, 2004.
19. Lagiou P, Rossi M, Lagiou A, Tzonou A, La Vecchia C, et al.: Flavonoid intake and liver cancer: a case-control study in Greece. Cancer Causes Control 19, 813-818, 2008.
20. Fink BN, Steck SE, Wolff MS, Britton JA, Kabat GC, et al.: Dietary flavonoid intake and breast cancer risk among women on Long Island. Am J Epidemiol 165, 514-523, 2007.
21. Peterson J, Lagiou P, Samoli E, Lagiou A, Katsouyanni K, et al.: Flavonoid intake and breast cancer risk: a case-control study in Greece. Br J Cancer 89, 1255-1259, 2003.
22. Kurahashi N, Iwasaki M, Sasazuki S, Otani T, Inoue M, et al.: Soy isoflavone consumption is not associated with increased risk of advanced prostate cancer. Cancer Epidemiol Biomarkers Prev 16, 2169, 2007.
23. Chang ET, Lee VS, Canchola AJ, Clarke CA, Purdie DM, et al.: Diet and risk of ovarian cancer in the California Teachers Study cohort. Am J Epidemiol 165, 802-813, 2007.
24. Gallus S, Talamini R, Giacosa A, Montella M, Ramazzotti V, et al.: Does an apple a day keep the oncologist away? Ann Oncol 16, 1841-1844, 2005.
25. Franceschi S, Negri E, Salvini S, Decarli A, Ferraroni M, et al.: Reproducibility of an Italian food frequency questionnaire for cancer studies: results for specific food items. Eur J Cancer 29 A, 2298-2305, 1993.
26. Decarli A, Franceschi S, Ferraroni M, Gnagnarella P, Parpinel MT, et al.: Validation of a food-frequency questionnaire to assess dietary intakes in cancer studies in Italy: results for specific nutrients. Ann Epidemiol 6, 110-118, 1996.
27. Salvini S, Parpinel M, Gnagnarella P, Maisonneuve P, and Turrini A: Banca di composizione degli alimenti per studi epidemiologici in Italia. Milano, Italy: Istituto Europeo di Oncologia, 1998.
28. Gnagnarella P, Parpinel M, Salvini S, Franceschi S, Palli D, et al.: The update of the Italian food composition database. J Food Comp Analysis 17, 509-522, 2004.
29. Liggins J, Bluck LJ, Runswick S, Atkinson C, Coward WA, et al.: Daidzein and genistein contents of vegetables. Br J Nutr 84, 717-725, 2000.
30. Liggins J, Bluck LJ, Runswick S, Atkinson C, Coward WA, et al.: Daidzein and genistein content of fruits and nuts. J Nutr Biochem 11, 326-331, 2000.
31. Torres AL, Lozano C, Julia L, Sanchez-Baeza FA, Anglada AM, et al.: Cysteiny-flavan-3-01 conjugates from grape procyanidins. Antioxidant and antiproliferative properties. Bloorg Med Chem 10, 2497-2509.
32. Breslow NE and Day NE: Statistical methods in cancer research: Vol. I. The analysis of case-control studies, IARC Scientific Publications No. 32. Lyon, France: IARC, 1980.
33. Willett W and Stampfer MJ: Total energy intake: implications for epidemiologic analyses. Am J Epidemiol 124, 17-27, 1986.
34. Rossi M, Garavello W, Talamini R, Negri E, Bosetti C, et al.: Flavonoids and the risk of oral and pharyngeal cancer: a case-control study from Italy. Cancer Epidemiol Biomarkers Prev 16, 1621-1625, 2007. (Pubitemid 47294828)
35. Rossi M, Garavello W, Talamini R, La Vecchia C, Franceschi S, et al.: Flavonoids and risk of squamous cell esophageal cancer. Int J Cancer 120, 1560-1564, 2007. (Pubitemid 46355394)
36. Garavello W, Rossi M, McLaughlin JK, Bosetti C, Negri E, et al.: Flavonoids and laryngeal cancer risk in Italy. Ann Oncol 18, 1104-1109, 2007. (Pubitemid 47050503)
37. Rossi M, Negri E, Talamini R, Bosetti C, Parpinel M, et al.: Flavonoids and colorectal cancer in Italy. Cancer Epidemiol Biomarkers Prev 15, 1555-1558, 2006.
38. Rossi M, Negri E, Parpinel M, Lagiou P, Bosetti C, et al.: Proanthocyanidins and the risk of colorectal cancer in Italy. Cancer Causes Control 21, 243-250, 2010.
39. Bosetti C, Spertini L, Parpinel M, Gnagnarella P, Lagiou P, et al.: Flavonoids and breast cancer risk in Italy. Cancer Epidemiol Biomarkers Prev 14, 805-808, 2005. (Pubitemid 40478539)
40. Rossi M, Negri E, Lagiou P, Talamini R, Dal Maso L, et al.: Flavonoids and ovarian cancer risk: a case-control study in Italy. Int J Cancer 123, 895-898, 2008.
41. Bosetti C, Bravi F, Talamini R, Parpinel M, Gnagnarella P, et al.: Flavonoids and prostate cancer risk: a study in Italy. Nutr Cancer 56, 123-127, 2006. (Pubitemid 46417670)
42. Bosetti C, Rossi M, McLaughlin JK, Negri E, Talamini R, et al.: Flavonoids and the risk of renal cell carcinoma. Cancer Epidemiol Biomarkers Prev 16, 98-101, 2007. (Pubitemid 46174270)
43. Franceschi S, Talamini R, Barra S, Baron AE, Negri E, et al.: Smoking and drinking in relation to cancers of the oral cavity, pharynx, larynx, and esophagus in northern Italy. Cancer Res 50, 6502-6507, 1990. (Pubitemid 20348768)
44. La Vecchia C, Chatenoud L, Franceschi S, Soler M, Parazzini F, et al.: Vegetables and fruit and human cancer: update of an Italian study. Int J Cancer 82, 151-152, 1999.
45. La Vecchia C and Franceschi S: Nutrition and gastric cancer with a focus on Europe. Eur J Cancer Prev 9, 291-295, 2000.
46. Bobe G, Peterson JJ, Gridley G, Hyer M, Dwyer JT, et al.: Flavonoid consumption and esophageal cancer among black and white men in the United States. Int J Cancer 125, 1147-1154, 2009.
47. Cotterchio M, Boucher BA, Manno M, Gallinger S, Okey A, et al.: Dietary phytoestrogen intake is associated with reduced colorectal cancer risk. J Nutr 136, 3046-3053, 2006. (Pubitemid 44878571)
48. Akhter M, Inoue M, Kurahashi N, Iwasaki M, Sasazuki S, et al.: Dietary soy and isoflavone intake and risk of colorectal cancer in the Japan public health center-based prospective study. Cancer Epidemiol Biomarkers Prev 17, 2128-2135, 2008.
49. Oba S, Nagata C, Shimizu N, Shimizu H, Kametani M, et al.: Soy product consumption and the risk of colon cancer: a prospective study in Takayama, Japan. Nutr Cancer 57, 151-157, 2007.
50. Akhter M, Iwasaki M, Yamaji T, Sasazuki S, and Tsugane S: Dietary isoflavone and the risk of colorectal adenoma: a case-control study in Japan. Br J Cancer 100, 1812-1816, 2009.
51. Theodoratou E, McNeill G, Cetnarskyj R, Farrington SM, Tenesa A, et al.: Dietary fatty acids and colorectal cancer: a case-control study. Am J Epidemiol 166, 181-195, 2007.
52. Theodoratou E, Kyle J, Cetnarskyj R, Farrington SM, Tenesa A, et al.: Dietary flavonoids and the risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 16, 684-693, 2007.
53. Cos P, De Bruyne T, Hermans N, Apers S, Berghe DV, et al.: Proanthocyanidins in health care: current and new trends. Curr Med Chem 11, 1345-1359, 2004.
54. Hoensch HP and Kirch W: Potential role of flavonoids in the prevention of intestinal neoplasia: a review of their mode of action and their clinical perspectives. Int J Gastrointest Cancer 35, 187-195, 2005.
55. Gosse F, Guyot S, Roussi S, Lobstein A, Fischer B, et al.: Chemopreventive properties of apple procyanidins on human colon cancer-derived metastatic SW620 cells and in a rat model of colon carcinogenesis. Carcinogenesis 26, 1291-1295, 2005.
56. Kim YJ, Park HJ, Yoon SH, Kim MJ, Leem KH, et al.: Anticancer effects of oligomeric proanthocyanidins on human colorectal cancer cell line, SNU-C4. World J Gastroenterol 11, 4674-4678, 2005.
57. Kaur M, Singh RP, Gu M, Agarwal R, and Agarwal C: Grape seed extract inhibits in vitro and in vivo growth of human colorectal carcinoma cells. Clin Cancer Res 12, 6194-6202, 2006.
58. Faria A, Calhau C, de Freitas V, and Mateus N: Procyanidinsas antioxidants and tumor cell growth modulators. J Agric Food Chem 54, 2392-2397, 2006.
59. Nandakumar V, Singh T, and Katiyar SK: Multi-targeted prevention and therapy of cancer by proanthocyanidins. Cancer Lett 269, 378-387, 2008.
60. Das N and Pereira T: Effects of flavonoids on thermal autoxidation of palm oil-structure activity-relationship. J Am Oil Chem Soc 67, 255-258, 1990.
61. Hayes R, Bookwalter Q, and Bayley E: Antioxidant activity of soybean flour and derivatives-a review. J Food Sci 42, 1527-1532, 1977.
62. Cotterchio M, Boucher BA, Kreiger N, Mills CA, and Thompson LU: Dietary phytoestrogen intake-lignans and isoflavones-and breast cancer risk (Canada). Cancer Causes Control 19, 259-272, 2008.
63. Zhang M, Xie X, Lee AH, and Binns CW: Soy and isoflavone intake are associated with reduced risk of ovarian cancer in southeast China. Nutr Cancer 49, 125-130, 2004.
64. Lukanova A and Kaaks R: Endogenous hormones and ovarian cancer: epidemiology and current hypotheses. Cancer Epidemiol Biomarkers Prev 14, 98-107, 2005.
65. Gercel-Taylor C, Feitelson AK, and Taylor DD: Inhibitory effect of genistein and daidzein on ovarian cancer cell growth. Anticancer Res 24, 795-800, 2004.
66. Spinella F, Rosano L, Di Castro V, Decandia S, Albini A, et al.: Green tea polyphenol epigallocatechin-3-gallate inhibits the endothelin axis and downstream signaling pathways in ovarian carcinoma. Mol Cancer Ther 5, 1483-1492, 2006.
67. Gates MA, Tworoger SS, Hecht JL, De Vivo I, Rosner B, et al.: A prospective study of dietary flavonoid intake and incidence of epithelial ovarian cancer. Int J Cancer 121, 2225-2232, 2007.
68. Magee PJ and Rowland IR: Phyto-oestrogens, their mechanism of action: current evidence for a role in breast and prostate cancer. Br J Nutr 91, 513-531, 2004.
69. Travis RC, Spencer EA, Allen NE, Appleby PN, Roddam AW, et al.: Plasma phyto-oestrogens and prostate cancer in the European Prospective Investigation into Cancer and Nutrition. Br J Cancer 100, 1817-1823, 2009.
70. Wilson RT, Wang J, Chinchilli V, Richie JP, Virtamo J, et al.: Fish, vitamin D, and flavonoids in relation to renal cell cancer among smokers. Am J Epidemiol 170, 717-729, 2009.